Latest: FDA Approves New Biosimilar for Oncology Treatment

Johnson & Johnson Innovative Medicine Partner with Multiple Myeloma Ireland to launch the 2025 “Miles for Myeloma” Challenge

0 Mins
Johnson & Johnson (J&J) staff embarked on the first mile of the 2025 ‘Miles for Myeloma’ challenge with Multiple Myeloma Ireland (MMI), kicking off the annual month-long challenge at the state-of-the-art biopharmaceutical site in Ringaskiddy, Cork. This September, during Blood Cancer Awareness Month, the J&J team from Cork and the commercial organisation in Dublin have joined forces to walk, run, cycle and swim to clock up Miles for Myeloma and raise funds for this important cause. MMI is the only charitable organisation in Ireland working to empower people affected by multiple myeloma and related conditions to live full lives, offer…
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago